NeuroDetect vs Neuropathy Tracker

NeuroDetect is a mobile app that detects peripheral neuropathy in patients treated with chemotherapy. Peripheral neuropathy is a common side effect of chemotherapy that causes numbness, tingling, and/or pain in the hands and feet. There are no effective agents to treat or prevent peripheral neuropathy. Neuropathy is typically monitored during treatment by patients reporting symptoms to their clinical team. NeuroDetect collects patient-reported neuropathy symptoms by questionnaire and has functional tests that may be indicative of neuropathy development. These functional tests require integration with Apple’s ResearchKit to collect movement data. This private app is only available to participants in a clinical trial and is for research purposes only.

The Neuropathy Tracker is a Mobile Health (mHealth) tool for ambulatory self-assessment of neuropathy, which can be done by the patient at home. The app was designed in an iterative, user-centered design (UCD) process involving neurologists, patients, and healthy subjects, thereby ensuring a high degree of clinical validity and usability. The assessment methodology in the app applies state-of-the-art neuropathy assessment methods, and the app embodies a user-friendly and systematic assessment flow that guides the patient through the self-assessment.